TY - JOUR
T1 - Adults’ acceptance of covid-19 vaccine for children in selected lower-and middle-income countries
AU - Bono, Suzanna Awang
AU - Siau, Ching Sin
AU - Chen, Won Sun
AU - Low, Wah Yun
AU - de Moura Villela, Edlaine Faria
AU - Pengpid, Supa
AU - Hasan, M. Tasdik
AU - Sessou, Philippe
AU - Ditekemena, John D.
AU - Amodan, Bob Omoda
AU - Hosseinipour, Mina C.
AU - Dolo, Housseini
AU - Fodjo, Joseph Nelson Siewe
AU - Colebunders, Robert
N1 - Funding Information:
Funding: This research was funded by VLIRUOS (Flemish Interuniversity Council for University Development Cooperation).
Publisher Copyright:
© 2021 by the authorsLicensee MDPI, Basel, Switzerland.
PY - 2022/12/22
Y1 - 2022/12/22
N2 - Since emergency approval of COVID-19 vaccines for children aged between 12 and 15 years old was recently obtained in the United States and Europe, we aimed to assess the willingness to vaccinate children with a COVID-19 vaccine in lower-and middle-income countries (LMICs). Therefore, we launched an online cross-sectional survey in several LMICs. Questions relating to socio-demographic information, knowledge of COVID-19, level of fear/worry of being infected with COVID-19, and willingness to vaccinate children with the COVID-19 vaccine at 50%, 75% and 95% effectiveness levels, were asked. Of the 6571 participants (mean age = 39 ± 14 years), 64.0%, 72.6%, and 92.9% were willing to vaccinate children at 50%, 75%, and 95% effectiveness levels, respectively. Respondents who were undergraduates, who were more worried/fearful about COVID-19, had higher knowledge scores regarding COVID-19, and a higher belief that COVID-19 vaccination is important to protect others, were more willing to accept COVID-19 vaccination of children. COVID-19 vaccination of children will limit the spread of the virus, especially in schools; it may decrease the need for school closures which has a negative effect on child development. Findings from this study are useful for health promotion strategies during COVID-19 vaccination implementation among children in LMICs.
AB - Since emergency approval of COVID-19 vaccines for children aged between 12 and 15 years old was recently obtained in the United States and Europe, we aimed to assess the willingness to vaccinate children with a COVID-19 vaccine in lower-and middle-income countries (LMICs). Therefore, we launched an online cross-sectional survey in several LMICs. Questions relating to socio-demographic information, knowledge of COVID-19, level of fear/worry of being infected with COVID-19, and willingness to vaccinate children with the COVID-19 vaccine at 50%, 75% and 95% effectiveness levels, were asked. Of the 6571 participants (mean age = 39 ± 14 years), 64.0%, 72.6%, and 92.9% were willing to vaccinate children at 50%, 75%, and 95% effectiveness levels, respectively. Respondents who were undergraduates, who were more worried/fearful about COVID-19, had higher knowledge scores regarding COVID-19, and a higher belief that COVID-19 vaccination is important to protect others, were more willing to accept COVID-19 vaccination of children. COVID-19 vaccination of children will limit the spread of the virus, especially in schools; it may decrease the need for school closures which has a negative effect on child development. Findings from this study are useful for health promotion strategies during COVID-19 vaccination implementation among children in LMICs.
KW - Africa
KW - Bangladesh
KW - Brazil
KW - Caretaker
KW - Children
KW - COVID-19 vaccination
KW - Lower-and middle-income countries
KW - Malaysia
KW - Parents
KW - Thailand
UR - http://www.scopus.com/inward/record.url?scp=85121707303&partnerID=8YFLogxK
U2 - 10.3390/vaccines10010011
DO - 10.3390/vaccines10010011
M3 - Article
C2 - 35062672
AN - SCOPUS:85121707303
SN - 2076-393X
VL - 10
JO - Vaccines
JF - Vaccines
IS - 1
M1 - 11
ER -
